<DOC>
	<DOCNO>NCT01127750</DOCNO>
	<brief_summary>This study assess tolerability safety health outcome relapse MS patient take FTY720 .</brief_summary>
	<brief_title>Tolerability Safety Health Outcomes Relapsing Multiple Sclerosis ( MS ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>1865 year age , must relapse MS Patients type MS relapse Patients history chronic immune disease Patients history certain cancer Diabetic patient certain eye disorder Patients certain immunosuppressive medication heart medication Patients certain heart condition Patients certain lung condition Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Relapsing multiple sclerosis</keyword>
	<keyword>MS</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>health outcome</keyword>
</DOC>